Immune Activation in the Pathogenesis of HIV Infection: Causes and Consequences
Netanya Sandler Utay, MD
Assistant Professor of Internal Medicine
UTHealth, McGovern Medical School
Houston, TX
Videos of live meetings of PRN in NYC are owned and published by Physicians’ Research Network, Inc.
Copyright © 2018. All rights reserved.
Dr. Netanya Sandler Utay was born and raised in Dallas, Texas. She completed her B.S. in Molecular Biophysics and Biochemistry at Yale University in 1998. She attended medical school at Baylor College of Medicine, during which time she was a Howard Hughes Medical Institute-National Institutes of Health Research Scholar. At the NIH, she became interested in the study of host-pathogens interactions, focusing on mediators of fibrosis in a mouse model of schistosomiasis. After completing medical school, she ventured to the University of Washington for residency in internal medicine and then returned to the NIH for infectious diseases fellowship. During her fellowship, Dr. Utay investigated the causes and consequences of inflammation in HIV infection. She joined the Division of Infectious Diseases at the University of Texas Medical Branch at Galveston in February 2013, where she continued her research, before moving to the University of Texas Health Science Center at Houston. She maintains a busy outpatient HIV clinic, chairs several clinical studies locally, and oversees a laboratory focused on the causes and consequences of inflammation in acute and chronic infections with HIV. In addition, Dr. Utay serves as vice-chair of the AIDS Clinical Trials Group End Organ Disease and Inflammation Transformative Science Group and helps oversee all studies related to end organ disease and inflammation within the ACTG.
At the completion of this educational session, learners will:
- Appreciate the role that immune activation in acute and chronic HIV infection plays in establishing and perpetuating infection.
- Know the drivers of immune activation in acute and chronic HIV infection.
- Understand the consequences of immune activation in chronic HIV infection.
This PRN CME activity is funded in part by unrestricted educational grants from:
Gilead Sciences; Janssen Therapeutics, a division of Janssen Products, LP; Merck & Co; and ViiV Healthcare.
